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Tissue engineering is widely recognized as a promising approach for bone repair and reconstruction. Several attempts have been
made to achieve materials that must be compatible, osteoconductive, and osteointegrative and have mechanical strength to
provide a structural support. Composite scaﬀolds consisting in biodegradable natural polymers are very promising constructs.
Hydroxyapatite (HAp) can support alginate as inorganic reinforcement and osteoconductive component of alginate/HAp
composite scaﬀolds. Therefore, HAp-strengthened polymer biocomposites oﬀer a solid system to engineer synthetic bone
substitutes. In the present work, HAp was incorporated into an alginate solution and internal gelling was induced by addition of
slowly acid-hydrolyzing D-gluconic acid delta-lactone for the direct release of calcium ions from HAp. It has been previously
demonstrated that alginate-based composites eﬃciently support adhesion of cancer bone cell lines. Human dental pulp stem
cells (DPSCs) identiﬁed in human dental pulp are clonogenic cells capable of diﬀerentiating in multiple lineage. Thus, this study
is aimed at verifying the mineralization and diﬀerentiation potential of human DPSCs seeded onto scaﬀolds based on alginate
and nano-hydroxyapatite. For this purpose, gene expression proﬁle of early and late mineralization-related markers,
extracellular matrix components, viability parameters, and oxidative stress occurrence were evaluated and analyzed. In
summary, our data show that DPSCs express osteogenic diﬀerentiation-related markers and promote calcium deposition and
biomineralization when growing onto Alg/HAp scaﬀolds. These ﬁndings conﬁrm the use of Alg/HAp scaﬀolds as feasible
composite materials in tissue engineering, being capable of promoting a speciﬁc and successful tissue regeneration as well as
mineralized matrix deposition and sustaining natural bone regeneration.
1. Introduction
Tissue engineering is widely recognized as one of the most
promising approaches for bone repair and reconstruction in
orthopaedics [1]. Bone is a complex and hierarchical tissue
with nano-hydroxyapatite and collagen representing the
major portions [2]. Several attempts have been made in order
to achieve feasible materials with osteoconductive and
osteointegrative properties to provide a structural support
[3]. Indeed, the major role of bone is to provide a morpholog-
ical framework, mechanical strength, blood pH regulation,
and maintenance of calcium and phosphate levels to assist
metabolic processes [2]. As far as dental restoration is
concerned, regenerative endodontics is a promising ﬁeld of
tissue engineering that is aimed at achieving results using
stem cells associated with responsive molecules and scaﬀolds.
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In particular, the combination of composite materials and
stem cells in the site of implantation is considered an ideal
alternative treatment to traditional root canal therapy [4].
Thus, growing cells from a small biopsy, followed by their
culture in porous scaﬀold to form a new tissue, is the goal
of tissue engineering [3]. Artiﬁcial scaﬀolds are temporary
structures designed to sustain and promote cell adhesion,
migration, proliferation, and diﬀerentiation through their
chemical and physical properties [2]. Both bioactive ceramics
and polymers have been developed for use as bone composite
scaﬀolds. Composite scaﬀolds consisting in biodegradable
natural polymers are very promising constructs, endowed
with excellent biocompatibility and suitable mechanical
properties. Moreover, they can be loaded with growth and
diﬀerentiation factors involved in bone formation. Natural
polymers oﬀer the advantage of being very similar to the
physiological macromolecular environment of cells [1, 5].
Among natural polymers, polysaccharides are very versatile,
able to be decorated with signal molecules and to interact
with inorganic components. Alginates belong to a family of
linear copolymers capable of forming stable gels in the
presence of millimolar concentrations of calcium or other
divalent cations [6]. Alginates can be eﬀectivelymanufactured
into porous three-dimensional biodegradable networks, and,
in combination with hydroxyapatite (HAp) as inorganic
reinforcement and osteoconductive element and/or with
other bioactive components, they can constitute solid systems
sustaining natural bone regeneration [1, 7, 8].
Over the last decade, the discovery of diﬀerent types of
multipotent stem cells from human adult tissues has led to
a rapid breakthrough in the ﬁeld of regenerative medicine.
They can potentially regenerate diﬀerent types of tissues
when loaded on suitable scaﬀolding structures that direct
stem cell fate [9]. Adult mesenchymal stem cells (MSCs),
primarily isolated from the bone marrow, were identiﬁed to
be multipotent stem cells with the ability of diﬀerentiating
into cells of mesodermal (osteocytes, chondrocytes, and
adipocytes), ectodermal (neurons), and endodermal origins.
Other eminent sources of adult MSCs include placenta,
umbilical cord, amniotic ﬂuid, adipose tissue, dental pulp,
breast milk, and synovium [10]. The oral cavity as well as
the extracted teeth constitute a remarkable source since they
produce a variety of somatic stem cells [11]. The major diﬀer-
ences in the stem cells arising fromdiﬀerent sources are exhib-
ited in their immunophenotypes. These diﬀerences have
implications on proliferation, diﬀerentiation, and immuno-
modulation of MSCs from the respective sources. Dental
pulp stem cells (DPSCs) have been reported to have higher
proliferative ability than bone marrow- and adipose tissue-
derived MSCs [10, 12–14]. They continuously divide and
diﬀerentiate into various cell types, for instance, cells belong-
ing to osteogenic, dentinogenic, adipogenic, neurogenic,
chondrogenic, and myogenic lineage. Moreover, dental pulp
can be easily isolated from the surgical waste derived from
deciduous tooth or wisdom tooth extraction [15]. The very
low morbidity of the anatomical site after the collection of
the pulp, the high eﬃciency of the extraction procedure of
stem cells from the pulp tissue, the diﬀerentiation ability,
and the demonstrated interactivity of stem cells derived
from dental pulp with biomaterials for tissue engineering
applications hold to DPSCs a great potential for clinical
purposes [11, 16]. Although it has been well demonstrated
that MSCs from various sources are able to sustain bone
regeneration [17], only recent tissue engineering approaches
have shown that DPSCs constitute a valuable cell source for
the healing of bone tissue when supported by a suitable
scaﬀold [18–20].
Also compared to equal volumes of bone marrow, dental
pulp contains a higher number of mesenchymal stem cells
[21, 22]. In this light, due to the presence of a higher undiﬀer-
entiated population, DPSCs are a suitable stem cell source in
order to obtain diﬀerent kinds of tissue including dental pulp
tissues, dentin, or bone. These cells proliferate and diﬀerenti-
ate into mature cells that produce an extracellular mineral-
ized matrix. Remarkably, it seems that redox homeostasis
might be essential for osteogenic diﬀerentiation [23]. MSCs
are known to have low levels of intracellular ROS and high
levels of glutathione, a key antioxidant. They also constitu-
tively express high levels of enzymes required to manage oxi-
dative stress. In terms of redox regulation, numerous recent
reports describe the importance of oxidants on MSC diﬀer-
entiation into osteoblast-like cells. Elevated levels of ROS,
deﬁned as oxidative stress, lead to arrest of the MSC cell cycle
and apoptosis [23, 24].
The diﬀerentiation stage of DPSCs greatly inﬂuences
both the speed of matrix deposition and the quality of the
newly formed one [22, 25]. Among several components,
water with some dissolved noncollagenous organic matter
is the third component of the mineralized matrix, while the
ratios of hydroxyapatite-to-collagen-to-water volume and
weight fraction are not constant. Wet collagen and hydroxy-
apatite mineral crystal agglomerations interpenetrate each
other, forming the mineralized ﬁbril at a scale of several
hundred nanometers [2]. The aim of this study is to verify
the mineralization potential of human DPSC growth in the
presence of composite scaﬀolds based on alginate and
nano-hydroxyapatite, which has been already described and
characterized by Turco et al. [1]. It has been shown that these
scaﬀolds can eﬃciently sustain adhesion, colonization, and
matrix deposition of osteoblast-like cells without any addi-
tional chemical modiﬁcation of alginate. Moreover, they
have adequate structural and physical-chemical properties
for being used as scaﬀolds in bone tissue engineering strat-
egies. In the present paper, the gene expression proﬁle of
early and late mineralization-related markers, extracellular
matrix components, viability parameters of DPSCs, and
expression of bone sialoprotein II (BSP II) were evaluated
and analyzed. We further provide experimental evidence that
the activation of the enzymatic antioxidant catalase is crucial
for cell survival.
2. Materials and Methods
2.1. Preparation of Alginate and HAp Composites (Alg/HAp
Scaﬀolds). Alg/HAp composite scaﬀolds were prepared after
having mixed alginate 2% (w/v) and HAp at diﬀerent con-
centrations in water using the calcium release method. HAp
in powder was homogenously dissolved into a stirred
2 Stem Cells International
solution of alginate in water, followed by the addition of GDL
60mM to release calcium ions from HAp. Aliquots of this gel
were then pipetted and incubated in a 24-well tissue culture
plate (Costar, Cambridge, MA) for 24h at room temperature
in order to achieve a complete geliﬁcation. Hydrogels were
then stepwise cooled, immersing tissue culture plates in a
liquid cryostat using an aqueous solution of ethylene glycol
(3 : 1 in water) as refrigerant ﬂuid. Temperature was lowered
stepwise from 20 up to −20°C using 5°C steps with a 30min
interval for equilibration. Samples were then freeze-dried
for 24 h to obtain porous scaﬀolds. As a control, pure alginate
gels (HAp-free) were prepared by replacing HAp with
CaCO3 (30mM of Ca
2+). Hap-free gels were then processed
as their counterpart with HAp. Alg/HAp scaﬀolds were
further characterized as previously described [1].
2.2. Alg/HAp Scaﬀold Sterilization and Preparation for Cell
Culture. Alg/HAp scaﬀolds underwent two cycles of steriliza-
tion under a UV light (15W) for 1 hour. After that, they were
rehydrated in a sterile aqueous solution of 5mM CaCl2 and
1% penicillin/streptomycin under weak magnetic agitation
for 20 minutes. Next, every scaﬀold was gently squeezed by
means of a clamp and placed in a Falcon® 12-Well Clear Flat
Bottom Not Treated Multiwell Cell Culture Plate. MEM
ALPHA medium supplemented with 10% FBS and 1%
penicillin/streptomycin (all purchased by EuroClone, Milan,
Italy) was immediately added up to the brim of each well in
order to cover up the entire scaﬀold surface. Then scaﬀolds
were conditioned by the medium overnight, placing the
multiwell plate at 37°C and 5% CO2.
2.3. Isolation and Cultivation of DPSCs. According to the
Italian Legislation and the code of ethical principles for med-
ical research involving human subjects of the World Medical
Association (Declaration of Helsinki), young donors who
underwent extraction of the third molar signed an informed
consent. This project has received the approval of the Local
Ethical Committee of the University of Chieti-Pescara
(approval number 1173, date of approval 31/03/2016). After
having obtained dental pulp samples from surgical proce-
dures, DPSCs were handled and cultivated as previously
described [22].
DPSCs were then analyzed by ﬂow cytometry in order to
characterize the cells by their immunophenotype. Molecular
markers commonly applied to identify mesenchymal stem
cells were detected as described in a previous work from
our group [26].
2.4. Cell Seeding on Alg/HAp Scaﬀolds. After being character-
ized by ﬂow cytometry, DPSCs were cultured and expanded
in MEM ALPHA medium supplemented with 10% FBS and
1% penicillin/streptomycin (all purchased by EuroClone,
Milan, Italy) up to passage 7. Cell cultures were then trypsi-
nized (Trypsin/EDTA 1x, EuroClone, Milan, Italy), and cells
were collected by centrifugation at 1200 rpm for 10 minutes
at room temperature. DPSCs were counted by Trypan blue
dye exclusion, and 5× 104 cells resuspended in 130μl of com-
plete MEM ALPHA medium were used for cell seeding on
each scaﬀold. The same cell number was used to seed DPSCs
on polystyrene (named in ﬁgures as DPSCs). After having
discarded the medium from the overnight conditioning, scaf-
folds were once again squeezed to eliminate the excess of
medium and placed on a fresh Falcon 12-Well Clear Flat
Bottom Not Treated Multiwell Cell Culture Plate. Next,
DPSCs were seeded drop by drop on the scaﬀolds and imme-
diately placed at 37°C and 5% CO2 for 3 h. Finally, a complete
MEM ALPHA medium was added (named in ﬁgures as
“Scaﬀold”, i.e., DPSC-laden scaﬀolds). Where necessary,
the complete MEM ALPHA medium supplemented by dif-
ferentiation agents (named in ﬁgures as DPSCs +DM and
Scaﬀold +DM, i.e., DPSC-laden scaﬀolds in the presence
of diﬀerentiation medium) was added. Complete DM was
supplemented by L-ascorbic acid 100μM, dexamethasone
10 nM, β-glycerol phosphate disodium salt pentahydrate
5mM (all purchased by Sigma-Aldrich, MI, USA), and
potassium phosphate monohydrate 1.8mM (Alfa Aesar,
MA, USA). DPSCs seeded on polystyrene and DPSCs onto
Alg/HAp scaﬀolds with or without DM were incubated for
1, 3, 7, 14, 21, and 28 days, refreshing the medium every 72 h.
2.5. Alizarin Red S Staining. To assess calcium deposition,
Alizarin Red S staining was carried out on DPSC cultures.
On days 7, 14, 21, and 28, the cell supernatant was discarded
and cells were washed twice with PBS with Ca/Mg. After that,
cultures were ﬁxed with 4% paraformaldehyde (PFA) for
30minutes and then washed with PBS. Samples were after-
wards incubated with Alizarin Red S (40mM in deionized
water) for 30 minutes in the dark. After that, DPSCs were
washed three times with deionized water and samples were
observed under a phase-contrast light microscope (Leica,
Wetzlar, Germany) equipped with a CoolSNAP camera to
acquire computerized images (Photometrics, Tucson, AZ).
2.6. Alkaline Phosphatase Activity. Alkaline phosphatase
(ALP) catalyzes the hydrolysis of phosphate esters in alkaline
buﬀer and produces an organic radical and inorganic phos-
phate. The activity of ALP was analyzed in cell supernatants
using the Alkaline Phosphatase Assay Kit (Colorimetric)
(Abcam, Cambridge, UK). The kit uses p-nitrophenyl phos-
phate (pNPP) as a phosphatase substrate which turns yellow
(λmax = 405 nm) when dephosphorylated by ALP. Cell super-
natants were collected after 1, 3, 7, 14, 21, and 28 days of
culture. After collection, 80μl/well of sample was loaded in
a Falcon 96-Well Clear Flat Bottom TC-Treated Culture
Microplate in duplicate. Next, 50μl of pNPP 5mM/well
was added and the plate was incubated for 1 hour at room
temperature in the dark. After that, 20μl of stop solution
was pipetted into each well and the absorbance output was
measured at 405nm by means of a microplate reader
(Multiskan GO, Thermo Scientiﬁc, MA, USA). Each test
was performed in triplicate. The calculation of ALP activity
(U/l/min) was carried out following the manufacturer’s
speciﬁcations, and each obtained value was normalized on
its protein content (μg of proteins/sample) measured by the
BCA assay.
2.7. Quantiﬁcation of Human Collagen Type I. Levels of
collagen type I in the culture medium were quantiﬁed by
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means of ELISA (human collagen type 1 ELISA, Cosmo Bio,
Tokyo, Japan). After 1, 3, 7, 14, 21, and 28 days, cell superna-
tants were collected and ELISA assay was performed. Cell
supernatants were pipetted, and the blue conjugate and the
yellow antibody were added. After 2 h of incubation at room
temperature on a plate shaker, wells were washed and then
incubated with the pNPP substrate for 45min. Finally, a stop
solution was added and optical density (OD) was measured
at 450nm by means of a microplate reader (Multiskan GO,
Thermo Scientiﬁc, MA, USA). Each test was performed in
triplicate. The concentration of collagen type I was calculated
using a standard curve generated with speciﬁc standards
provided by the manufacturers. Each obtained collagen con-
centration (μg/ml) was normalized on the protein content
(μg of proteins/sample) measured by the BCA assay.
2.8. Protein Extraction and BCA Assay. After having dis-
carded the supernatants, DPSCs cultured on polystyrene
were washed twice with PBS, trypsinized, and collected by
centrifugation at 1200 rpm for 10 minutes. Pellets were then
washed twice with cool PBS and kept on ice. As regard
DPSCs’ growth onto scaﬀolds, they were put in a sodium
citrate buﬀer solution at pH = 7 4 under vigorous magnetic
agitation in order to decompose scaﬀolds without damaging
cells. This buﬀer solution was made by 50mM sodium citrate
tribasic dehydrate, 100mM sodium chloride, and 10mM
sucrose (all purchased from Sigma-Aldrich, MI, USA). After
being dissolved in the buﬀer solution, scaﬀolds and DPSCs
were collected by centrifugation at 1500 rpm for 10 minutes
and pellets were washed twice with cool PBS. After having
discarded the washing solution, 0.5ml of lysis buﬀer enriched
with a protein inhibitor cocktail (PBS, 1% IGEPAL CA-630,
0.5% sodium deoxycholate, 0.1% SDS, 10mg/ml PMSF,
1mg/ml aprotinin, 100mM sodium orthovanadate, and
50μg/ml leupeptin, all purchased from Sigma-Aldrich, MI,
USA) was added and samples were kept on ice for 30min.
Then, the lysed pellets were resuspended and kept on ice
for a further 30min. Following centrifugation for 15min at
20,000g, the supernatant was collected as the whole cell
fraction. Protein concentration in the whole cell lysate was
determined using bicinchoninic acid assay (QuantiPro™
BCA Assay Kit for 0.5–30μg/ml protein, Sigma-Aldrich,
Milan, Italy) following the manufacturer’s instructions.
Brieﬂy, cell lysates were diluted 1 : 150 in 150μl of deionized
water and an equal volume of QuantiPro BCA assay mix was
added. Samples were incubated 2 h at 37°C, and the absor-
bance signal generated was measured at 562nm in a micro-
plate reader (Multiskan GO, Thermo Scientiﬁc, MA, USA).
Each test was performed in triplicate. Analyses of the obtained
OD were carried out using GraphPad Prism version 5.01 for
Windows (GraphPad Software, San Diego, CA). The concen-
tration of protein was calculated using a standard curve gen-
erated with speciﬁc standards provided by themanufacturers.
2.9. Cytotoxicity Assay. Cytotoxicity occurrence was assessed
by means of the CytoTox 96® Non-Radioactive Cytotoxicity
Assay (Promega, WI, USA). The kit measures lactate dehy-
drogenase (LDH), a stable cytosolic enzyme that is released
upon cell lysis. Released LDH in culture supernatants is
measured with coupled enzymatic assay, which results in
the conversion of a tetrazolium salt (iodonitrotetrazolium
violet (INT)) into a red formazan product. The amount of
color formed is proportional to the number of lysed cells.
After having collected supernatants at days 1, 3, 7, 14, 21,
and 28, 50μl was transferred to a Falcon 96-Well Clear Flat
Bottom TC-Treated Culture Microplate in triplicate. An
equal volume of CytoTox 96 Reagent is added to each well
and incubated for 30 minutes. When a provided stop solution
was added, the absorbance signal was measured at 490nm
and 690nm (background) in a microplate reader (Multiskan
GO, Thermo Scientiﬁc, MA, USA). Each test was carried out
in triplicate. Assessment of the percentage of relative cytotox-
icity was calculated subtracting the background value and
normalizing the obtained OD with the protein content
(μg of proteins/sample) measured by the BCA assay.
2.10. Catalase Activity. To indirectly assess oxidative stress
occurrence, the analysis of the antioxidant enzyme catalase
activity was carried out. For this purpose, the Amplex® Red
Catalase Assay Kit was used (Molecular Probes, Invitrogen
Corporation, CA, USA). Catalase is a heme-containing redox
protein which prevents excess of intracellular hydrogen
peroxide (H2O2) converting this compound to water and
oxygen. In the assay, catalase—if working in samples—ﬁrst
reacts with H2O2 to produce water and oxygen (O2). Next,
the Amplex Red reagent reacts with a 1 : 1 stoichiometry with
any unreacted H2O2 in the presence of horseradish peroxi-
dase (HRP) to produce the highly ﬂuorescent oxidation
product, resoruﬁn. Therefore, as catalase activity increases,
the signal from resoruﬁn decreases. The absorbance was
measured at 560nm in a microplate reader (Multiskan GO,
Thermo Scientiﬁc, MA, USA). The results are typically plot-
ted by subtracting the observed ﬂuorescence from that of a
no-catalase control (complete MEM ALPHA medium and
complete medium with DM). Assessment of the relative cat-
alase activity (mU/ml) was calculated using a standard curve
generated with speciﬁc standards provided by the manufac-
turers and normalizing the obtained values with the protein
content (μg of proteins/sample) measured by the BCA assay.
2.11. RNA Extraction. Total RNA was extracted using TRI
Reagent (Sigma-Aldrich, St. Louis, MO). Brieﬂy, cell growth
onto Alg/HAp scaﬀolds was suspended in 500μl of TRI
Reagent and then centrifuged at 10,000 rpm for 10min at
4°C. The supernatant was added to 100μl of chloroform, then
shaken vigorously, incubated on ice for 15min, and centri-
fuged at 13,200 rpm for 20min at 4°C. RNA in aqueous phase
was precipitated with 250μl of isopropanol, stored for 30min
at −20°C, and pelletted by centrifugation at 13,200 rpm for
20min at 4°C. RNA pellet was washed with 500μl of 75% eth-
anol, air-dried, and ﬁnally resuspended in RNAse-free water.
In order to avoid the contamination of samples, DNA was
removed using a DNA-free kit (Life Technologies, Carlsbad,
CA). RNA concentration was determined by spectrophotom-
eter reading at 260 nm, and its purity was assessed by the
ratio at 260 and 280nm readings (BioPhotometer Eppendorf,
Hamburg, Germany). Samples were afterwards tested by
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electrophoresis through agarose gels and visualized by
staining with ethidium bromide, under UV light.
2.12. Reverse Transcription (RT) and Real-Time RT-
Polymerase Chain Reaction (Real-Time RT-PCR). In order
to reverse-transcribe 1μg of RNA, a high-capacity cDNA
Reverse Transcription Kit (Life Technologies) was used.
Twenty microliters of these solutions was stepwise incubated
in a 2720 Thermal Cycler (Life Technologies) initially at 25°C
for 10min, then at 37°C for 2 h and ﬁnally at 85°C for 5min.
Gene expression was determined by quantitative PCR using
TaqMan probe-based chemistry. Reactions were performed
in 96-well plates on an ABI PRISM 7900 HT Fast Real-
Time PCR System (Life Technologies). TaqMan probes and
PCR primers were obtained from Life Technologies (Taq-
Man Gene Expression Assays (20x): Hs00154192_m1 for
BMP2, Hs00231692_m1 for RUNX2, and Hs01866874_s1
for SP7), and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (Life Technologies, part number 4333764 F) was
used as a housekeeping gene. Each ampliﬁcation reaction
was performed with 10μl of TaqMan Fast Universal PCR
Master Mix (2x), No AmpErase UNG (Life Technologies),
1μl of primer-probe mixture, 1μl of cDNA, and 8μl of
nuclease-free water. No-template control was used to check
for contamination. A reverse transcriptase minus control
was included for SP7 gene assay. Thermal cycling conditions
were 95°C for 20 s, followed by 40 cycles of ampliﬁcation at
95°C for 1 s and 60°C for 20 s. Sequence Detection System
software, ver. 2.3 (Life Technologies), elaborated gene
expression data. The comparative 2−ΔΔCt method was used
to quantify the relative abundance of mRNA (relative quan-
tiﬁcation). Real-time PCR analysis was performed in three
independent experiments. In each experiment, we included
one cDNA sample for each experimental condition. Ampliﬁ-
cation was carried out in triplicate for each cDNA sample in
relation to each of the investigated genes.
2.13. Immunoblotting. DPSC lysates (20μg/sample) were
electrophoresed on a 4–20% SDS-PAGE gel (ExpressPlus™
10x8, GenScript Biotech Corporation, China) and trans-
ferred to nitrocellulose membranes further blocked in 5% of
nonfat milk, 10mmol/l Tris pH7.5, 100mM NaCl, and
0.1% Tween 20. Membranes were then probed for mouse
anti-β-actin monoclonal antibody (Sigma-Aldrich, St. Louis,
MO, USA) (primary antibody dilution 1 : 10,000) and mouse
monoclonal anti-BSP II (Santa Cruz Biotechnology, CA,
USA) (primary antibody dilution 1 : 200) and incubated in
the presence of speciﬁc conjugated IgG horseradish perox-
idase. Immunoreactive bands were identiﬁed using the
ECL detection system (Amersham Int., Buckinghamshire,
UK) and analyzed by densitometry. Densitometric values,
expressed as the percentage of the integrated optical inten-
sity ratio of BSP II and β-actin, were estimated by the
ChemiDoc XRS system using the QuantiOne 1-D analysis
software (Bio-Rad, Richmond, CA, USA).
2.14. Statistics. Statistical analysis was performed using the
analysis of variance (one-way ANOVA) with post hoc test
(Tukey) for RT-PCR analysis and the t-test. Results were
expressed as mean ± SD. Values of p < 0 05 were considered
statistically signiﬁcant.
3. Results
3.1. Formation of Mineralized Nodules in DPSCs Exposed to
Diﬀerentiation Medium. The production of the extracellular
mineralized matrix by DPSCs was evaluated through
Alizarin Red S staining. As shown in Figure 1, cells cultured
in the presence of diﬀerentiation agents (DM) are crowded
by a mineralized matrix rich in calcium precipitates stained
in red (lower panel), revealing that the generation of calcium
precipitates is time-dependent. Quite the opposite, cells from
the control group show fewer Alizarin Red-positive regions
starting from 7 days of culture up to 28 days (upper panel).
3.2. Alkaline Phosphatase Activity and Collagen Type I
Release in DPSCs Exposed to Medium Enriched with
Mineralizing Agents. In order to evaluate mineralization
occurrence and to conﬁrm Alizarin Red S staining observa-
tion, ALP activity was quantiﬁed in DPSCs committed to
osteogenic diﬀerentiation (DPSCs+DM) compared to cells
cultivated in normal growth medium (DPSCs) (Figure 2(a)).
After 1 day of culture, only a slight diﬀerence among DPSCs
and DPSCs +DM in terms of ALP activity is detectable
(5.33× 10−4 U/l/min and 4.6× 10−4 U/l/min, resp.). As
far as DPSC culture is concerned, ALP activity decreases
DPSCs
DPSCs
+
DM
50 휇m 
50 휇m 
50 휇m 
50 휇m 
50 휇m 
50 휇m 
50 휇m 
50 휇m 
7 days 14 days 21 days 28 days
Figure 1: Mineralization of dental pulp stem cells (DPSCs) assessed by Alizarin Red staining. The upper panel shows the Alizarin Red
staining of pulp cells after 7, 14, 21, and 28 days of culture without diﬀerentiation medium (DM). The presence of mineralized nodules in
cultures exposed to DM after 7, 14, 21, and 28 days is displayed in the lower panel. Magniﬁcation 40x.
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in a time-dependent manner, being assessed at 3.88× 10−4
U/l/min after 3 days of culture and at 1.54× 10−4 U/l/min
after 28 days. A similar tendency can be observed for
DPSCs exposed to DM, being signiﬁcantly dropped after 7
and 14 days (5.13× 10−5 U/l/min and 7.75× 10−5 U/l/min,
resp.). Cells exposed to diﬀerentiation agents for 28 days
produce the highest peak in terms of ALP activity, being sig-
niﬁcantly increased compared to DPSCs cultivated in normal
growth medium (1.28× 10−3 U/l/min versus 1.54× 10−4).
After that, collagen type I secretion was quantiﬁed to
evaluate the extracellular matrix modiﬁcations and the
osteogenic commitment (Figure 2(b)). As regard DPSCs cul-
tivated in normal growth medium, after a slight decrease
occurred up to 7 days, the levels of secreted collagen type I
arise again to the level of the ﬁrst day of culture. In parallel,
cells exposed to diﬀerentiation agents show a decrease in col-
lagen type I production reaching the lowest values after 7 and
14 days (0.311μg/ml and 0.349μg/ml). After 21 days, this
tendency is reversed and the production of collagen type I
is signiﬁcantly higher with respect to the ﬁrst day of culture
(1.98μg/ml).
3.3. Protein Quantiﬁcation and Cytotoxicity. As a measure
of cell seeding eﬃciency, the BCA assay was performed on
the whole cell lysates derived from DPSCs cultivated onto
Alg/HAp scaﬀolds compared to the ones from DPSCs under
normal cell conditions with or without diﬀerentiation agents
(Figure 3(a)). As regards control group (DPSCs), the protein
content gradually arises over the time of the experiments,
being almost 9-fold augmented after 28 days compared to 1
and 3 days of culture (315.17μg, 36.57μg, and 47.40μg, resp.).
A similar tendency can be observed for DPSCs cultivated in
the presence of diﬀerentiation agents up to 14 days when the
absolute highest protein content is registered (27.97μg,
51.18μg, 238.45μg, and 251.87μg). After that, a slight
decrease occurs, with the protein content assessed at
171.35μg after 21 days and at 203.84μg after 28 days.
Although this fall is signiﬁcant compared to 14 and 7 days of
culture, the amount of proteins remains consistent with
respect to early stages (Figure 3(a)). When DPSCs were culti-
vated onto Alg/HAp scaﬀolds, the protein pool is signiﬁcantly
reduced compared to DPSCs alone after 1 day of culture
(11.95μg and 36.57μg, resp.). The shrinkage in terms of pro-
tein content can be observed up to 14 days, when the absolute
lower value is registered (7.64μg). Surprisingly, a 7-fold
increase is detected (54.61μg) after 21 days of culture. Never-
theless, the protein pool is once again lowered after 28 days. A
similar tendency can be registered when DPSCs are cultivated
onto scaﬀolds in the presence of diﬀerentiation agents (scaf-
fold +DM). For instance, the amount of protein after 21 days,
when there is the peak for DPSCs and scaﬀold, is even lower
(44.57μg).
After having monitored cell seeding eﬃciency by means
of protein quantiﬁcation, the cytotoxicity of Alg/HAp scaf-
folds on DPSCs was assessed in terms of LDH release
(Figure 3(b)). There are no signiﬁcant changes in the per-
centage of LDH released from cells exposed to DM or culti-
vated alone, as the highest peaks for these experimental
conditions are assessed at 1.18% after 28 days of culture of
DPSCs alone. Quite the opposite, a substantial elevation in
the percentage of LDH released can be detected when DPSCs
are grown onto Alg/HAp scaﬀolds. More in detail, the
amount of enzyme secreted after 1 day is 11-fold higher than
the one released from DPSCs alone (11.06% versus 1.06%).
After 3 days of cell culture on the scaﬀold, this rise is even
more enhanced, reaching a 32.7-fold increase if compared
to DPSCs alone (26.20% versus 0.80%). After this peak, the
percentage of LDH released gradually decreases, being
assessed at 0.68% after 21 days of culture (Figure 3(b)). Once
again, a rise in terms of LDH release is observed after 28 days
of culture (15.57%). A similar progress can be registered
when DPSCs are cultivated onto scaﬀolds in the presence of
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Figure 2: Alkaline phosphatase (ALP) activity and collagen type I release in dental pulp stem cells (DPSCs). (a) Bar graph showing the
enzymatic activity of ALP (U/ml) normalized on the protein content (μg/sample) after 1, 3, 7, 14, 21, and 28 days of culture. ∗p < 0 05,
7, 14, and 28 d of DPSCs +DM versus DPSCs. (b) The bar graph represents collagen type I secretion from DPSCs with or without DM after
1, 3, 7, 14, 21, and 28 days of culture. Results are normalized on values obtained from DPSCs cultured for 1 day without DM after being
proportioned on the protein content (μg/sample). ∗p < 0 05 28 d DPSCs +DM versus DPSCs. ∗∗p < 0 01 21 d DPSCs +DM versus DPSCs.
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DM, with the exception of the 14 days of culture, when the
percentage of LDH is quite higher with respect to DPSCs
and scaﬀold alone (15.52% versus 6.93%).
3.4. Formation of Oxidative Stress. To correlate the elevated
cytotoxicity to an oxidative stress occurrence, the activity of
catalase was monitored and quantiﬁed (Figure 4). When
DPSCs are cultured alone, the activity of the antioxidant
enzyme gradually decreases, being 27.04mU/ml after 1 day
of culture and 1.31mU/ml after 28 days. Very likely, when
DPSCs are exposed to DM, the activity of catalase lowers
with respect to DPSCs without DM up to 14 days of culture.
After 21 days of culture in the presence of DM, catalase activ-
ity is doubled with respect to DPSCs alone (4.54mU/ml ver-
sus 2.14mU/ml) and the diﬀerence is even more enhanced
after 28 days (4.31mU/ml versus 1.31mU/ml). Observing
catalase activity in DPSCs growth onto scaﬀolds, a dramatic
rise can be detected compared to both DPSCs exposed to
DMandDPSCs alone (Figure 4).More in detail, values appear
similar as regard 1 and 3 days of culture (38.21mU/ml and
37.58mU/ml, resp.). At 7 days of culture onto scaﬀolds, the
absolute highest value of catalase activity is registered
(91.12mU/ml). After that peak, the activity of the enzyme
progressively decreases, reaching 24.94mU/ml after 28 days.
When DM is added to the DPSCs/scaﬀold culture, the
tendency results to be very similar to the previous one. The
catalase activity after 7 days is slightly lower (87.70mU/ml)
but still consistent compared to DPSCs +DM. As above,
the activity of the enzyme lessens, being 21.05mU/ml after
28 days of culture.
3.5. Gene Expression Proﬁle ofMineralization-RelatedMarkers.
To demonstrate that a commitment to mineralization is
established, relative gene expression of BMP2, RUNX2,
and SP7 was analyzed by RT-PCR on DPSCs alone and
growth onto Alg/HAp scaﬀolds along with their counter-
part exposed to DM (Figure 5). At length, the expression
of the early diﬀerentiation gene BMP2 (Figure 5(a)) is not
signiﬁcantly changed after 3 days of cell culture in the
presence of DM. Notably, there is a consistent elevation
of BMP2 when DPSCs are exposed to DM for 7 days.
After that, values revert to the ones of the control group.
When cells grow onto scaﬀolds, a signiﬁcant positive peak
is registered after 7 days of culture (1.805 fold increase).
As regard DPSCs/scaﬀold culture +DM, the expression
of BMP2 is dramatically increased earlier than 7 days,
being elevated already after 1 day of culture and even
more after 3 and 7 days (1.357-, 1.402-, and 2.798-fold
increase, resp.).
Next, gene expression of RUNX2 was analyzed, which is
found expressed here at later stages than BMP2
(Figure 5(b)). For instance, there is a climax after 21 days
when DPSCs are grown onto scaﬀold (1.479-fold increase)
with respect to both DPSCs alone and DPSCs +DM. When
cells are cultivated in the presence of the scaﬀold and exposed
to DM, two positive pulses of RUNX2 gene expression can be
registered. The ﬁrst one is after 3 days of culture, and the
second—more dramatic—is observed after 21 days (1.910-
and 3.233-fold increase, resp.).
Finally, the expression of the late diﬀerentiation gene SP7
was evaluated. Generally speaking, there are no signiﬁcant
diﬀerences up to 21 days of culture. After 28 days, the expres-
sion of SP7 is consistently enhanced when DPSCs are culti-
vated onto scaﬀolds (1.390-fold increase) and this tendency
is even more evident when DM is added to the DPSC/scaﬀold
model (2.272-fold increase).
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Figure 3: Protein content and cytotoxicity assay on dental pulp stem cells (DPSCs) in the presence of alginate/hydroxyapatite scaﬀolds. (a)
The bar graph represents the quantiﬁcation of protein content (μg/sample) measured by the bicinchoninic acid (BCA) assay of DPSCs in the
presence of alginate/hydroxyapatite scaﬀolds over the diﬀerent experimental conditions. ∗p < 0 05 7, 14, and 28 d DPSCs +DM versus DPSCs;
1, 3, 7, and 14 d scaﬀold versus DPSCs; 7, 14, and 21 d scaﬀold +DM versus DPSCs +DM. ∗∗p < 0 01 7, 14, 21, and 28 d DPSCs versus 1 d
DPSCs; 21 d scaﬀold versus DPSCs; 28 d scaﬀold +DM versus scaﬀold. (b) Lactate dehydrogenase (LDH) released from DPSCs seeded on
alginate/hydroxyapatite scaﬀolds with or without DM. ∗∗p < 0 01 1, 3, 7, 14, 21, and 28 d scaﬀold versus DPSCs; 1, 3, 7, 14, 21, and 28 d
scaﬀold +DM versus DPSCs +DM. Scaﬀold =DPSC-laden scaﬀolds; scaﬀold +DM=DPSC-laden scaﬀolds in the presence of
diﬀerentiation medium.
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3.6. ALPActivity and Collagen Type I Release in DPSCGrowth
onto Alg/HAp Scaﬀolds. Finally, to further conﬁrm DPSCs’
osteogenic commitment when cultured onto Alg/HAp scaf-
folds in the presence or not of DM, the activity of ALP and
the release of collagen type I were monitored (Figure 6).
The presence of DM does not inﬂuence ALP activity after 1
day of culture, with U/l/min being very similar to the one of
DPSCs on scaﬀold alone (Figure 6(a)). A positive peak can
be observed when DPSCs are cultured onto scaﬀolds for 3
days. As deduced from the bar graph, this is the highest abso-
lute value registered, being assessed at 0.0493U/l/min. When
DM is added to the culture, ALP activity slightly lowers, but
remaining consistent (0.0401U/l/min). After 7, 14, and 21
days of culture, there are only weak ﬂuctuations of ALP activ-
ity, while it is quite elevated after 28 days when DPSCs are
cultured onto scaﬀolds without DM.
In parallel, the concentration of collagen type I in cell
supernatants was evaluated comparing all the values to the
concentration after 1 day of culture of DPSCs on scaﬀold
without DM (Figure 6(b)). A time-dependent concentration
increase can be detected for DPSC growth onto scaﬀolds,
with the release of collagen 1.32-fold higher after 3 days
and 6.50-fold higher after 28 days with respect to 1 day of
culture. Very likely but even more consistently, the secretion
of collagen type I when DPSCs are grown onto scaﬀolds in
the presence of DM is time-dependently increased. Indeed,
the release of collagen after 28 days is 13-fold higher if
compared to the one after 3 days (3.01-fold versus 39.46-
fold, resp.).
3.7. BSP II Expression in DPSCs Seeded on HAp/Alg Scaﬀolds.
To conﬁrm the osteogenic diﬀerentiation of DPSCs grown
onto scaﬀolds in the presence or not of DM, the expression
of the noncollagenous protein BSP II, implied in the regula-
tion of bone mineralization, was analyzed by means of
Western blotting. Densitometric values show a peak after 7
days of culture, registering a signiﬁcant increased value when
DPSCs are grown onto scaﬀolds without DM (Figure 7).
After that, BSP II is notably expressed after 21 and 28 days
when the DM is present.
4. Discussion
DPSCs isolated from human postnatal dental pulp tissues
can give rise to multilineage diﬀerentiation in vitro and
generate related mineralized tissues in vivo [27]. Bone
and dentine extracellular matrix proteins are similar, con-
sisting primarily of type I collagen, acidic proteins, and
proteoglycans. Although collagen forms the lattice for
deposition of calcium and phosphate assisting formation
of carbonate apatite, noncollagenous proteins are believed
to control initiation and growth of the crystals [28]. For
this purpose, Alizarin Red S staining was carried out on
our system. More in detail, DPSCs cultured on polystyrene
exposed to medium enriched by diﬀerentiation agents
show calcium nodule deposition from 7 days of culture
compared to cells from the control group (Figure 1). The
dimension of calcium nodules arises in a time-dependent
manner in DPSCs cultured in the presence of DM with
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Figure 4: Catalase activity of dental pulp stem cells (DPSCs) in the presence of alginate/hydroxyapatite scaﬀolds. Bars display the modulation
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respect to DPSCs’ growth in normal medium. In parallel,
we evaluated ALP activity and secretion of collagen type I
in the same experimental conditions. Despite diﬀerent
ﬂuctuations, both parameters increased at late stages of
culture, for instance, at 28 days. This is coherent with pre-
vious studies and literature [29], and the authors of the
present work are quite conﬁdent on the functionality of the
experimental system in committing cells to mineralized
matrix deposition.
For most regenerative strategies, an organic scaﬀold is
used to provide a surface on which cells may adhere, grow,
and spatially organize [30]. In the present paper, a 3D biode-
gradable porous scaﬀold prepared from a binary mixture
composed by alginate and HAp was used. DPSCs have to
interpenetrate this porous structure and proliferate to give
birth to newly produced mineralized tissue. Due to the
diﬃcult handling of this experimental 3D cell culture and
the diﬃculty in obtaining data on cell seeding eﬃciency and
viability with classical and commercially available assays,
we measured the amount of proteins to indirectly evaluate
DPSC attachment and interpolation into scaﬀolds. Not
surprisingly, DPSCs better adhered on polystyrene, with the
amount of proteins increased over the time of the culture.
In the DPSC/scaﬀold system, an increment in the amount
of protein was consistent after 21 days. In parallel, the protein
pool was slightly lowered when DM is added. This let us
speculate that DPSCs were more proliferating on scaﬀolds
alone. Next, to evaluate the cytotoxic response of DPSCs on
Alg/HAp scaﬀolds, the LDH assay was carried out. Observing
in parallel the amount of proteins and the release of LDH, it is
plausible to assume that nonproliferating DPSCs in the
presence of scaﬀolds ﬁt on necrotic cell death, especially after
3 days of culture. Quite the opposite, the LDH release, which
gradually lowered from 7 days up to 21 days, let us hypothe-
size a compensatory mechanism. Data on LDH release
agreed with the rise in protein amount at 21 days, when the
release of LDH is very low and very close to the one of the
control group (Figure 3). The hypothesized compensatory
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Figure 5: Gene expression proﬁles of diﬀerentiation- and mineralization-associated marker genes in dental pulp stem cells (DPSCs) in the
presence of alginate/hydroxyapatite scaﬀolds. Graphs represent the relative gene expression of BMP2 (a), RUNX2 (b), and Osterix (SP7)
(c) in DPSCs over the various experimental conditions. Data are expressed as fold increase on relative mRNA levels of DPSCs cultivated
in growth medium not enriched with diﬀerentiation agents. (a) ∗p < 0 05 14 d scaﬀold +DM versus DPSCs; 7 d DPSCs +DM versus
DPSCs. ∗∗∗∗p < 0 001 7 d scaﬀold versus DPSCs; 1, 3, and 7 d scaﬀold +DM versus DPSCs. (b) ∗∗∗p < 0 005 21 d scaﬀold versus DPSCs; 3
and 21 d scaﬀold +DM versus DPSCs. (c) ∗∗p < 0 01 28 d scaﬀold versus DPSCs. ∗∗∗∗p < 0 001 scaﬀold +DM versus DPSCs.
Scaﬀold =DPSC-laden scaﬀolds; scaﬀold +DM=DPSC-laden scaﬀolds in the presence of diﬀerentiation medium.
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mechanism seems to default after 28 days in the same exper-
imental conditions when a rise of LDH released and a
decrease in the protein amount is registered. Most relevantly,
DM seems to even enhance the reduction of the protein
amount and rise of LDH release as evidenced by bar and
trend graphs after 14 days of culture.
Hydrogen peroxide scavenging is governed by catalase,
which is the enzyme that converts H2O2 in H2O and O2
[31]. To correlate the dramatic LDH release from DPSCs cul-
tured onto scaﬀolds for 3 days and the recovering of the sys-
tem after 7 days and on, we evaluated the activity of the
antioxidant enzyme catalase (Figure 4). As shown by the
bar graph, oxidative stress was not occurring in both DPSCs
from the control group and the one exposed to DM, with the
activity of catalase being physiologically compatible. On the
other way round, the activity of catalase in DPSCs cultivated
on Alg/HAp scaﬀolds was consistent already from early
stages. Indeed, after 7 days, the highest absolute value is
registered, making plausible the hypothesis that DPSCs
produced a large amount of H2O2 when growing onto scaf-
folds. To counteract oxidative stress occurrence, cells
respond by activating antioxidant molecules; among them,
catalase is one of the terminal regulators [32]. Redox
homeostasis is crucial for osteogenic commitment, diﬀeren-
tiation, and cell survival [23]. Likewise, here DPSCs
escaped from necrotic cell death, through the activation
of catalase, as evidenced by the decrement of LDH released
and the massive increase of catalase activity after 7 days
(Figures 3 and 4).
The tissue engineering goal is not only cell proliferation
and the lack of cell cytotoxic responses against the foreign
material, but overall the production of newly born tissues
and then stem cell commitment to osteogenic diﬀerentiation.
Data from literature has demonstrated that seven days
after H2O2 treatment, DPSCs showed signiﬁcant reduction
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Figure 6: Alkaline phosphatase (ALP) activity and collagen type I release in dental pulp stem cells (DPSCs) in the presence of alginate/
hydroxyapatite scaﬀolds. (a) Bar graph showing the enzymatic activity of ALP (U/ml) normalized on the protein content (μg/sample) after
1, 3, 7, 14, 21, and 28 days of culture of DPSC growth onto scaﬀolds. ∗p < 0 05 3 and 28 d scaﬀold versus 1 d scaﬀold; 3 d scaﬀold +DM
versus 1 d scaﬀold +DM. (b) The bar graph represents collagen type I secretion from DPSCs cultured on scaﬀolds with or without DM
after 1, 3, 7, 14, 21, and 28 days. Results are normalized on values obtained from DPSCs cultured on scaﬀolds for 1 day without DM after
being proportioned on the protein content (μg/sample). ∗p < 0 05 14 and 28 d scaﬀold +DM versus scaﬀold and scaﬀold +DM.
Scaﬀold =DPSC-laden scaﬀolds; scaﬀold +DM=DPSC-laden scaﬀolds in the presence of diﬀerentiation medium.
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Figure 7: Bone sialoprotein II (BSP II) protein expression in
dental pulp stem cells (DPSCs) in the presence of alginate/
hydroxyapatite scaﬀolds by Western blotting analysis. Graph
represents densitometric values (%) of BSP II expression
normalized on β-actin expression. ∗p < 0 05 7 days scaﬀold versus 1
day scaﬀold; ∗p < 0 05 21 and 28 days scaﬀold +DM versus 1 day
scaﬀold +DM. Scaﬀold =DPSC-laden scaﬀolds; scaﬀold +DM=
DPSC-laden scaﬀolds in the presence of diﬀerentiation medium.
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in ALP activity compared with negative control and no
mineralized nodule deposition [34]. Hence, the evaluation
of the gene proﬁle of mineralization-related markers was
mandatory. We therefore analyzed the expression of
BMP2, RUNX2, and Osterix (SP7). The gene expression
of BMP2 is recognized to stimulate mineralization, and it
is considered the most osteogenic bone morphogenetic
protein which implies the early induction of diﬀerentiation
[35]. RUNX2 is an important transcriptional modulator of
diﬀerentiation, maturation, and homeostasis, downstream
from the BMP2 diﬀerentiation pathway [36]. In turn,
Osterix (SP7) is a transcription factor which plays a pivotal
role during the diﬀerentiation of progenitors into mature
cells in a step downstream of RUNX2 [37]. In our system,
expression of early, intermediate, and late diﬀerentiation
markers is consistent with data in literature [22]. More in
detail, BMP2 expression increased after 3 and 7 days in
DPSCs cultured on scaﬀolds indiﬀerently from the presence
of DM, in accordance with data of catalase activity. Beside a
spike after 3 days, RUNX2 was enhanced after 21 days mostly
when DM is present, in agreement with LDH release after the
same experimental time. As regards Osterix gene expression,
it was clearly increased after 28 days mainly in DPSCs/
scaﬀolds +DM, when the LDH amount was slightly
decreased with respect to scaﬀolds alone (Figure 5). Several
studies have reported the synthesis of many scaﬀolds
capable of sustaining pulp stem cell diﬀerentiation
in vitro in the presence of diﬀerentiation media, but only
two of them, namely, a polyvinyl alcohol- (PVA-) poly(ε)
caprolactone- (PCL-) hydroxyapatite-based bioceramic
[38] and a calcium phosphate cement scaﬀold loaded with
iron oxide nanoparticles [39], have been found to enhance
cell diﬀerentiation compared to cell monolayers cultured
on polystyrene due to the osteoinductive property of
the material.
To conﬁrm if DPSC enhanced mineralization when
cultured on Alg/HAp scaﬀolds, we reevaluated ALP activity
and collagen type I secretion. Data supported gene expres-
sion results, with ALP activity being strongly enhanced after
3 days of culture where DM was not inﬂuencing the activity
of the enzyme. This tendency was similar over the
experimental time, up to 28 days of culture (Figure 6(a)).
Conversely, the release of collagen type I seemed to be consis-
tently inﬂuenced by DM as shown in Figure 6(b). It is plausi-
ble to assume that this enhancement could be ascribed to the
presence of ascorbic acid present in the DM medium. This is
in agreement with data on literature which correlates the
release of collagen and extracellular matrix deposition with
exposures to ascorbate [40]. Finally, to strengthen DPSC’s
ability to diﬀerentiate into osteoblast-like cells, the expres-
sion of BSP II was analyzed. Among all, the dentin-bone non-
collagenous proteins consist in small integrin-binding ligand
N-linked glycoproteins (SIBLINGs). SIBLINGs are secreted
during the formation and mineralization of both dentin
and bone, and BSP is a highly posttranslationally modiﬁed
protein that is an abundant noncollagenous component
of the bone matrix. Moreover, in situ hybridization and
immunolocalization experiments have shown that BSP is
expressed in teeth during mineralization [41–43]. Our data
show that BSP II is highly expressed after 7, 21, and 28
days on DPSCs grown onto scaﬀolds in the presence of
DM in line with PCR results.
In summary, we provide evidence for osteoconductivity
of alginate/hydroxyapatite scaﬀolds that are able of eﬃ-
ciently sustaining adhesion, colonization, and matrix deposi-
tion of osteoblast-like cells. [1]. We show that DPSCs
express mineralization-related markers and proteins, deﬁ-
nitely promoting matrix deposition. Most importantly, this
physiological function is here related to redox homeostasis
controlled by the activation of catalase which as an enzy-
matic antioxidant enhances cell survival.
4.1. Limitations of the Study. Although the cellular
response towards oxidative stress is driven by a multidi-
mensional network of transcription factors and enzymes
and the measurement of catalase activity is only one aspect
of the molecular scenario occurring intracellularly, catalase
plays a crucial role in adaptive response to H2O2 and it
has been suggested that its role is somehow auxiliary to
that of glutathione peroxidase [33]. Furthermore, the dif-
ferentiation of osteoblasts implies the formation of an
extracellular matrix, which is rich in proteins. Due to the
diﬃculty in the experimental design, in the handling of
the three-dimensional cell culture and the speciﬁc proper-
ties of the material, to normalize ELISA and LDH results
with the amount of proteins was the only appropriate exper-
imental procedure because any other proliferation assays are
not feasible.
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Supplementary Materials
S1. DPSC immunophenotyping: data reported show the
representative immunophenotype proﬁle of DPSCs isolated
from the third molar at passage 4. Cells were found negative
for the lymphocyte-related CD45 (protein tyrosine phospha-
tase) and slightly positive for SSEA4 (stage-speciﬁc embryonic
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antigen 4), while they signiﬁcantly express CD90 (Thy-1),
CD73 (5′ nucleotidase), CD29 (integrin β1), and CD105
(endoglin), thus identifying a mesenchymal stem cell popula-
tion. (Supplementary Materials)
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